2.21 (-%)
As of Nov 21, 2024
Source:
Minerva Neurosciences, Inc. is a clinical-stage biopharmaceutical company focused on the development and commercialization of proprietary product candidates to treat patients suffering from central nervous system (“CNS”) diseases.
| Country | United States |
| Headquarters | waltham, massachusetts |
| Phone Number | 617-600-7373 |
| Industry | manufacturing |
| CEO | Remy Luthringer |
| Website | www.minervaneurosciences.com |